First Light Asset Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

First Light Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $27.2 Million - $39.6 Million	-465,572 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $4.43 Million - $6.44 Million	-71,264 Reduced 13.27%	465,572 $38.6 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $10.3 Million - $15.2 Million	-167,613 Reduced 23.79%	536,836 $35.6 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $18.1 Million - $35.3 Million	413,962 Added 142.51%	704,449 $54.1 Million
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $9.65 Million - $14.9 Million	290,487 New	290,487 $12.5 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.